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The relation of β-lactam antibiotics, β-lactam acylases and  








The remarkable catalytic power of 
enzymes, which combines a broad chemical 
scope, a high selectivity, a high rate enhancement 
and a high efficiency, makes them attractive 
catalysts for numerous conversions in industrial 
production of food, feed or fine chemicals. 
For centuries enzymes have been used in 
the form of fermentative organisms for the 
production of wine, cheese or bread. This is 
reflected in the name “enzyme”, which was 
introduced by F. W. Kuhne in 1878 to address the 
catalytic forces that were proposed to be present in 
living organisms and is derived from the Greek 
phrase ‘en zymē’ meaning “in leaven” (Bohinski, 
1987; Stryer, 1995). Despite the world-wide 
integration of enzymes in the manufacturing of 
food, it was not until the late nineteenth and early 
twentieth century that the mystery of enzymes was 
little by little elucidated and that their important 
biological role and industrial usefulness became 
evident. It started with the first reports of catalytic 
forces or enzymatic reactions outside living cells. 
In 1894, Fisher described the selective conversion 
of α-methylglucoside to glucose with a filtered 
aqueous extract of yeast (Fisher, 1894). 
Additionally, the Buchner brothers observed 
rather by surprise the conversion of sucrose into 
alcohol by cell-free extracts of yeast in 1897 
(Buchner, 1897). More information about the 
nature of enzymes was obtained in 1926, when 
Sumner gained an enzyme (urease) for the first 
time in its pure crystalline form. His claim that an 
enzyme was a protein substance was received with 
a lot of scepticism at that time, but the isolation of 
more enzymes by Sumner and other researchers 
led to the world-wide acceptance of the protein 
nature of enzymes in 1935 (Bohinski, 1987). How 
enzymes worked remained unclear for many 
additional years although Fisher envisioned that 
enzymes and substrates fitted like a lock and a 
key, which proved to be a rather accurate 
metaphor to illustrate the specificity of an enzyme. 
More insight in the binding of substrates and 
enzymatic mechanism was obtained when the first 
three-dimensional structure of an enzyme 
(lysozyme) was solved in 1965. In the mean time 
theories to describe the enzyme kinetics evolved 
and resulted in the famous and still used equations 
proposed by Michaelis and Menten in 1913. 
Today, more than 2500 enzymes have been 
identified and characterized of which around 250 
are used as biocatalysts in a commercial process 
either as pure enzymes or present in intact 
microbial cells (Woodley, 2000). 
The first industrial-valuable single-
enzymatic conversion is considered the 
hydroxylation of steroids which was performed 
with cells of Rhizopus nigricans and was 
introduced in 1952 (Woodley, 2000). However, 
ideally pure enzymes were employed. 
Unfortunately, enzymes were known as very 
sensitive and vulnerable to degradation and 
inactivation, which hampered their introduction on 
a large industrial scale for many years. A turning 
point is considered the creation of insoluble 
enzymes by immobilizing them on inert supports, 
which started in the 1960s. The immobilization 
technique facilitated easy recovery and reuse of 
enzymes and increased their stability (Woodley, 
2000). Additionally, when Klibanov discovered in 
1978 that enzymes can also work in organic 
solutions (Laere, 1996), the idea of enzymes being 
unworkable was weakened. In the mean time the 
growing awareness of the environment and the 
associated governmental regulations forced 
industry to implement cleaner or so-called greener 
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technology. Since the use of enzymes, either in 
isolated form or as whole-cell preparations, 
enables very efficient transformations in an 
aqueous environment (no-organic solvents 
needed) with few by-products, a rapid increase of 
the number of industrially implemented 
biocatalytic processes in the 1980s followed. At 
present, technological development in molecular 
biology, protein engineering and high-throughput 
screening allow the development of stable 
biocatalysts with tailor-made activity and 
selectivity, which surely will result in more 
industrial applications in the future (Schmid et al., 
2001; Zaks, 2001). 
Nowadays, enzymes are applied in the 
manufacturing of food, animal feed, detergents, 
pulp and paper, clothing and fine chemicals. An 
illustration of the application of an enzyme in the 
clothing industry is the replacement of washing 
with pumic stones by treatment with cellulase to 
give denim clothes their popular aged appearance. 
Cellulase removes the blue dye indigo attached to 
the surface of the fabric in a much more gentle 
way, which is beneficial for the strength of the 
garments and the industrial washing machines. An 
example of a compound that is produced with the 
assistance of an enzyme in the food industry can 
be found in the production of the artificial 
sweetener aspartame, in which the remarkable 
specificity of the enzyme thermolysin is 
effectively used. Thermolysin selectively couples 
L-phenylalanine methyl ester from a racemic 
mixture to the α-carboxyl group of an N-protected 
aspartic acid. Subsequent removal of the 
protective group of the produced dipeptide results 
in aspartame (Schmid et al., 2001). The 
selectively of thermolysin is essential as coupling 
of D-phenylalanine methyl ester would lead to a 
product with a bitter taste.  
A key application of immobilised 
biocatalysts can be found in the fine chemical 
industry in the cleavage by penicillin acylases of 
penicillin G (or V) to yield 6-aminopenicillanic 
acid (6-APA). This compound is needed for the 
production of semi-synthetic penicillins 
(Woodley, 2000), which still is predominantly 
produced chemically. However, also in this 
process the implementation of enzymes is ongoing 
(Bruggink, 2001; Bruggink et al., 1998). For 
example, the subject of our thesis, α-amino acid 
ester hydrolases (AEHs), are able to synthesise 
semi-synthetic antibiotics and are potentially very 
interesting to use as a biocatalyst. Before we will 
discuss these biocatalytically-interesting enzymes 
and the synthesis processes in more detail, an 




Discovery of β-lactam antibiotics 
Several scientists observed the inhibition 
on bacterial growth by contaminating molds, 
before Alexander Fleming discovered a fungus 
able to inhibit the growth of Staphylococcus 
aureus in 1928. He studied the fungus in more 
detail, identified it as Penicillium notatum, and 
called the anti-bacterial substance penicillin. 
Although Fleming used the penicillin-containing 
broth filtrate to show that the substance was not 
toxic to rabbits and could cure an eye infection, he 
mainly saw penicillin as a natural antiseptic 
(Bennet and Chung, 2001; Diggins, 2000). It was 
not until 1939 that the scientists Howard W. 
Florey and Ernst B. Chain purified penicillin and 
undoubtedly demonstrated its therapeutic value 
(Abraham, 1981; Bennet and Chung, 2001). 
























1942 the first large-scale fermentation of a 
Penicillium mold was performed in the United 
States. The subsequent availability of larger 
quantities of penicillin allowed effective treatment 
of infected wounds, which saved many soldiers 
from death during the war. 
The industrially introduced production-
strain Penicillium chrysogenum could produce 
next to penicillin G (Fig. 1, (1)) five other β-
lactam antibiotics, which differed only in their 
side chain (structures not shown). Research 
showed that the yield of a specific antibiotic could 
be increased by the addition of a precursor of its 
side chain, such as phenyl acetic acid in case of 
penicillin G. A search for possible side chain 
precursors led to the biosynthetic and acid stable 
penicillin V, which was obtained by adding 
phenoxy acetic acid to the fermentation broth 
(Savidge, 1984). Currently, about 16,000 tons of 
fermentative penicillin G and V are produced 
annually for therapeutic purposes (Bruggink, 
2001). 
A new penicillin-like antibiotic was 
discovered in 1948, when Giuseppe Brotzu 
isolated the mould Cephalosporium acremonium 
from a sewer pipe in Sardinia. Crude filtrates of 
this organism displayed the same activity against 
S. aureus as shown for the Penicillium strains and 
the antibacterial substance was named 
cephalosporin C (Nicholas et al., 1995). The 
relation between these antibiotics became evident 
from their chemical structures (Fig. 1), which 
showed the conservation of a common β-lactam 
ring. In penicillin G (1) the β-lactam ring is 
connected to a thiazolidine ring and in 
cephalosporin C (2) to a six-membered ring 
completing the so-called β-lactam nucleus. To the 
β-lactam nulei so-called side chains are attached, a 
phenylacetyl group in penicillin G and a D-2-
aminoadipyl moiety in cephalosporin C. The side 
chain strongly influences the antibacterial 
spectrum and the pharmacological properties of a 
β-lactam antibiotic. Depending on the nucleus, the 
β-lactam antibiotic is either referred to as a 
penicillin or a cephalosporin. Nowadays, the β-
lactam antibiotics are the most prescribed and 
effective drugs for bacterial infections and for 
their discovery of the almost non-toxic penicillin 
G, Fleming, Florey and Chain shared the Nobel 
Prize for physiology and medicine in 1944. 
 
Mode of action 
The β-lactam antibiotics are such effective 
antibacterial agents, mainly because they interfere 
with the synthesis of the bacterial cell wall. 
Depending on the type of bacterium, the cell wall 
consists of one or two lipid bilayers surrounded by 
an insoluble and strong peptidoglycan layer (Fig. 
2) (Schlegel, 1995). The peptidoglycan layer 
consists of peptidoglycan chains, which are 
formed by the repeating amino sugars N- 
acetylglucosamine (NAG) and N-acetylmuramic 
Figure 1. Structure of the β-lactam antibiotics 
penicillin G (1) and cephalosporin C (2). The acyl 
moiety is referred to as the side chain (left box); the 
ring structures form the so-called nucleus (right box). 
The arrow indicated the pharmacologically essential β-
lactam bond. The border between the side-chain and 































































acid (NAM) with a variable peptide chain attached 
to the carboxyl group of the NAM-unit (Fig. 2, 
inset). The peptidoglycan chains are covalently 
cross-linked to each other via short peptide-
bridges that stretch out from the third position of 
the peptide chain and is connected to the carboxyl 
group of a D-alanine residue from another peptide 
chain (Fig. 2, inset). This cross-linking is 
catalysed by transpeptidases, which react with the 
D-alanyl-D-alanine (D-Ala-D-Ala) moiety of the 
peptide attached to the NAM-unit to form a 
covalent acyl-enzyme complex upon release of the 
terminal D-alanine (Fig. 3, reaction 1). Subsequent 
aminolysis of this complex by the terminal amino 
group of the bridging peptide chain of another 
peptidoglycan results in the cross-link. To 
complete the cross-link, the terminal D-Ala group 
in the D-Ala-D-Ala moiety of the main peptide of 
the other peptidoglycan is removed by 
carboxypeptidases (Fig 2, inset) via hydrolysis of 
a similar covalent acyl enzyme complex. The β-
lactam antibiotics interfere with this process, as 
they are substrate analogues for these enzymes. 
They mimic the D-Ala-D-Ala moiety in which the 
amide bond in the β-lactam ring resembles the 
peptide bond of this dipeptide (Fig. 2). The 
peptidases are tempted by the highly reactive 
character of the β-lactam bond and react with the 
antibiotic, forming a covalent intermediate (Fig. 3, 
Figure 2. Schematic representations of the bacterial gram-negative (A) and gram-positive (B) 
cell wall. The outer membrane (OM) and cytoplasmic membrane (CM) both consist of a lipid bilayer 
with membrane proteins, some of which are forming pores in the membrane through which substances 
can diffuse in and out of the cell (freely adapted from [Nicholas, 1995 #3]). In the circle a detailed 
representation of the peptidoglycan cross link in S. aureus is given (freely adapted from [Bohinski, 
1987 #128]). Other abbreviations: PEP, peptidoglycan layer; PS, periplasmic space; PBP, penicillin-
binding proteins; NAG, N-acetyl glucosamine and NAM, N-acetyl muramic acid. The D-Ala residue in 


















































































































reaction 2). However, due to its high stability this 
penicilloyl-enzyme intermediate does not react 
further, irreversibly inactivating the enzyme. In 
this way β-lactam antibiotics covalently bind to a 
set of different enzymes, the so-called penicillin 
binding proteins (PBPs). Bacteria contain many 
different PBPs, each playing an important role in 
cell morphology and/or viability. By inactivating 
the transpeptidases and carboxypeptidases, a 
peptidoglycan layer with insufficient cross-links is 
formed, which is not strong enough to withstand 
the high internal osmotic pressure. Bacterial 
autolysins degrade these peptidoglycan strands, a 
process that proceeds unchecked in the presence 
of β-lactam antibiotics and eventually results in 
lysis of the growing bacterial cells that are 
exposed to the antibiotics (Abraham, 1981; 
Nicholas et al., 1995). 
 
Resistance to β-lactam antibiotics 
The first bacteria resistant to penicillin G 
were reported soon after the introduction of this 
antibiotic in medical practice (Abraham, 1981). 
Research showed that these bacteria thank their 
resistance mainly to the expression of the enzyme 
penicillinase (β-lactamase) that inactivates the 
penicillins by hydrolysing the β-lactam bond (Fig. 
Figure 3. Reaction scheme of the enzyme (E) transpeptidase with its substrate the D-Ala-D-
Ala terminus of a peptidoglycan unit (1) and its inhibitor penicillin (2). The inactivation of 
penicillin to penicilloic acid by β-lactamase (E in 3) is also shown, R: remainder of a peptide. The 















































3, reaction 3). In doing so, the β-lactamase forms 
a covalent intermediate with penicillin in the same 
way as the peptidases. However, in contrast to the 
penicilloyl-complexes of the PBPs, the 
intermediate with a β-lactamase is easily 
hydrolysed, resulting in inactive penicilloic acid 
and the recycled enzyme. Up to now more than 
250 β-lactamases have been identified, which are 
either plasmid or chromosomally encoded and 
vary in their substrate range, inhibition profiles, 
enzymatic properties and molecular structure. 
Especially, the plasmid-encoded β-lactamases 
contribute to bacterial resistance spreading as the 
plasmids can easily be transferred to other Gram 
negative or Gram positive bacteria by conjugation 
or by the action of transducing phages, 
respectively (Essack, 2001; Samaha-Kfoury and 
Araj, 2003). It is generally accepted that due to the 
intensive use of penicillin G in the 1950s, the β-
lactamase genes spread rapidly under pressure of 
natural selection. Additionally, the β-lactamases 
may rapidly adapt via point mutations to obtain 
activity with newly introduced β-lactam 
compounds (Samaha-Kfoury and Araj, 2003). As 
a result, the expression of β-lactamases is the most 
widespread and the most efficient bacterial 
mechanism to withstand the lethal action of β-
lactam antibiotics.  
Another defence mechanism which 
bacteria often employ to fight β-lactam antibiotics 
is changing the affinity of the essential PBPs for 
β-lactam antibiotics by mutation or recombination 
(Essack, 2001; Nicholas et al., 1995). 
Alternatively, gram-negative bacteria can alter the 
proteins that form the channels in their outer 
membrane in such a way that the diffusion of the 
β-lactam antibiotics through the membrane to 
reach the PBPs located in the perpiplasmic space 
is hindered, increasing the resistance significantly 
(Nicholas et al., 1995). 
 
Semi-synthetic β-lactam antibiotics 
In response to the evolution of β-
lactamases and to meet the demand for antibiotics 
that have a broader antibacterial spectrum and/or 
improved pharmacological properties, the search 
Figure 4. Examples of semi-synthetic β–lactam antibiotics. Shown are penicillins (upper) and 











































for new β-lactam antibiotics was started soon after 
the world-wide introduction of penicillin G. The 
elucidation of the structure of biosynthetic β-
lactam antibiotics with a broader antibacterial 
spectrum (penicillin N (a D-α-amino adipyl side 
chain connected to a 6-APA nucleus)) or with a 
higher acid stability (penicillin V (a 
phenoxymethyl side chain and a 6-APA nucleus)), 
indicated that variations in the side chain can alter 
the properties of a β-lactam antibiotic (Abraham, 
1981; Vandamme and Voets, 1974). A 
breakthrough for the synthesis of new β-lactam 
antibiotics was the production of the free β-lactam 
nucleus by a Penicillium strain grown in the 
absence of side chain precursors in 1959 
(Bruggink, 2001; Vandamme and Voets, 1974). 
Coupling of a synthetic 2,6-dimethyoxybenzoyl 
side-chain to the free 6-APA nucleus resulted in 
the first semi-synthetic β-lactam antibiotic 
methicillin (1960) that was effective against 
penicillin G resistant bacteria. Other clinically 
valuable semi-synthetic β-lactam antibiotics were 
obtained by the coupling of, for example, 
phenylglycine and hydroxyphenylglycine resulting 
in ampicillin (1961, Fig. 4), which has a broader 
activity spectrum against gram-negative bacteria, 
and amoxicillin (1972), an antibiotic with a high 
oral absorption, respectively (Bruggink, 2001; 
Nicholas et al., 1995). Cephalosporin C, with a 7-
aminocephalosporanic acid nucleus (7-ACA, Fig.1 
(2)), was a less effective antibiotic but appeared 
resistant to inactivation by β-lactamase activity 
(Abraham, 1987). Variations in the 3-acetoxy 
substituents of the cephalosporin nucleus in 
combination with the different side chains allowed 
for a much wider search for effective antibiotics 
and resulted in four generations of cephalosporins 
with improved and or specific properties. The 
explored combinations of side chains and nuclei 
have resulted in more than 50 penicillins and up to 
70 clinically useful cephalosporins (Neu, 1992). 
Next to the penicillin (penam) and cephalosporin 
(cephem) nuclei, several other nuclei (Fig. 5) from 
novel β-lactam antibiotics have been identified 
increasing the opportunities in the continuous 
fight against bacterial pathogens. Nowadays, the 
allergic reactions induced in some individuals are 
considered the major drawback of β-lactam 
antibiotics. However, the numerous possible 
combinations of synthetic side chains and β-
lactam nuclei allow for large varieties in both the 





The first enzyme able to cleave the amide 
bond in β-lactam antibiotics between the β-lactam 
nucleus and a carboxylic acid functionality, 
leaving the cyclic β-lactam amide bond intact was 
Figure 5. The basic β-lactam nuclei. The asterisks 




described as early as 1950 (penicillin G acylase 
from Escherichia coli ATCC 11105). Ten years 
later, the ability of the same enzyme to catalyse 
the reverse reaction (condensation) allowing 
formation of (semi-synthetic) β-lactam antibiotics 
was described (Vandamme and Voets, 1974). 
From then on, more enzymes displaying this 
activity with similar or different substrate ranges 
have been found in several prokaryotic species. 
The classical nomenclature of these so-
called β-lactam acylases is inspired by industrially 
relevant properties and based on the preferred β-
lactam antibiotic in hydrolysis. First, they are 
divided in penicillin and cephalosporin acylases, 
according to the nucleus of their preferred 
substrate, 6-aminopenicillanic acid (6-APA), or 7-
aminocephalosporanic acid (7-ACA) 
andderivatives thereof, respectively. Further 
grouping into subclasses is then based on the 
preferred side chain (Fig. 6). Since the affinity of 
the β-lactam acylases for the nucleus is very low, 
an alternative nomenclature based on the preferred 
acyl moiety has been proposed, naming them α-
acylamino-β-lactam acylhydrolases classes I to IV 
(Fig. 6) (Nam et al., 1985). The substrate-
specificity approach in both these nomenclatures 
is considered out dated as now more knowledge 
about the amino acid sequences, the molecular 
structure and catalytic mechanism of β-lactam 
acylases is available. However, in the literature 
still the classical nomenclature is used for the β-
lactam acylases and according to that we will 
describe these enzymes in more detail. 
 
Penicillin acylases 
The penicillin acylases are, according to 
their side chain preference, further divided in three 
classes, penicillin G, penicillin V and ampicillin 
Figure 6. Classical nomenclature of β-lactam acylases. Shown are the two nuclei of the penicillins 
(6-APA) and cephalosporins (7-ACA derivatives) and subsequently their possible natural side chains 
(at position R in the nucleus). The classical nomenclature, which is based on the preferred nucleus 
and subsequently, preferred side chain (R) is shown from the top of the figure. At the bottom of the 
figure the alternative nomenclature (class I to IV) based on only the preferred side chain is shown.  
β-Lactam acylases
Penicillins Cephalosporins























Class  I  II  III  IV
Cephalosporin C Glutaryl 7-ACA
Phenylacetyl Phenoxyacetyl α-Aminoacyl Glutaryl
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acylases (Fig. 6). 
Penicillin G acylases - Penicillin G 
acylases (PGAs) prefer penicillins with a 
phenylacetyl side chain (Fig. 6). One of the first 
known and industrially used β-lactam acylases is 
the penicillin acylase from Escherichia coli 
ATCC11105 (PA, EC 3.5.1.11), which is a 
periplasmic enzyme that is composed of an α- and 
β-subunit of 24 and 62 kDa, respectively. Cloning 
of the gene in 1986 showed that the PA is 
produced as a pre-pro-protein, which consists of a 
signal sequence, followed by the α-subunit, a 
spacer peptide, and the β-subunit. Additional 
studies revealed that the signal sequence is 
removed upon transport to the periplasm and there 
the spacer peptide is autocatalytically cleaved 
from the N-terminal side of the β-subunit and 
subsequently from the C-terminal side of the α-
subunit. This process yields the two separate 
subunits α and β which are held together by non-
covalent bounds (Hewitt et al., 2000; Schumacher 
et al., 1986). 
The mechanism of penicillin acylase 
involves the formation of an acyl-enzyme 
intermediate as described for the serine protease 
chymotrypsin. The crystal structure of PA was 
solved in 1995 and revealed a single-amino-acid 
catalytic centre (Duggleby et al., 1995). The 
hydroxyl group of the serine that is located at the 
N-terminal end of the β-subunit (βSer1) is 
activated, via a bridging water molecule, by its 
own α-amino group (Fig. 7). The serine oxygen 
attacks the acyl carbon atom of the substrate, 
forming an oxyanion tetrahedral intermediate (TI1) 
that is stabilised via hydrogen bonds by the main-
chain amide of Ala69 and the side chain nitrogen 
of Asn241. Rearrangement of electrons leads to 
the collapse of the intermediate resulting in release 
of the leaving group and a covalent acyl-enzyme 
intermediate. The enzyme is subsequently 
deacylated by a nucleophile, which leads via a 
similar tetrahedral intermediate (TI2) to the free 
enzyme and the acylation product of the 
nucleophile. In this way, β-lactam antibiotics can 
be cleaved to yield the free β-lactam nucleus and 
the side-chain carboxylic acid when the 
nucleophilic attack is performed by water 
(hydrolysis). However, when the acyl donor is an 
activated synthetic side chain (either an amide or 
an ester), a nucleophilic attack by a β-lactam 
nucleus such as 6-APA will yield a semi-synthetic 
β-lactam antibiotic through a process called 
aminolysis. Since the discovery of the catalytic 
mechanism for penicillin acylase, in which an N-
terminally located nucleophile is the key residue 
(Duggleby et al., 1995), several other enzymes 
have been found to posses a similar mechanism. 
These enzymes are referred to as the N-terminal 
nucleophile (Ntn) hydrolases and contain a typical 
four-layered αββα-core structure (Brannigan et 
al., 1995). 
Homologs of PA are found throughout the 
whole kingdom of prokaryotes (Arroy et al., 
2003). Well-studied PGAs are those from 
Kluyvera citrophila (Barbero et al., 1986; Martin 
et al., 1991), Proteus rettgeri (McDonough et al., 
1999), Alcaligenes faecalis (Verhaert et al., 1997), 
Bacillus megaterium (Chang and Bennet, 1967; 
Martin et al., 1995) and Arthrobacter 
viscosus(Konstantinovic et al., 1994; Verhaert et 
al., 1997). All these PGAs are located in the 
periplasmic space, expect for the acylases of the 
later two which are excreted (Gram positive 
bacteria). As the penicillin acylase from E. coli, 
the other PGAs are composed of two non-identical 













































































sequences show 83 to 29% identity to PA and 
based on sequence alignments it can be concluded 
that all these enzymes have an N-terminal 
catalytic serine and are derived from a precursor 
protein as described for PA. This was confirmed 
by the structure of P. rettgeri, which indeed 
showed the typical Ntn-hydrolase structure 
(McDonough et al., 1999). The PGAs have a 
similar substrate range although the kinetic 
parameters can vary among them. For example, 
the highest affinity (Km) for penicillin G is found 
for the A. faecalis enzyme (2 µM) (Verhaert et al., 
1997) while the acylase of B. megaterium ATCC 
14945 has a Km of 4.5 mM (Chang and Bennet, 
1967). By comparing the amino acid sequences 
and the different substrate specificities of the 
acylases it may be possible to identify residues 
that determine the catalytic action or biochemical 
properties of the enzyme. For example, the A. 
faecalis enzyme is more thermostable than E. coli 
PGA, which could be assigned to the unique 
Figure 7. Proposed catalytic mechanism of the Ntn-hydrolase penicillin acylase from E. coli. The 
deacylation by water results in hydrolysis of the substrate [adapted from Duggleby, 1995 #9]. B is either 
an oxygen (ester) or a nitrogen (amide), R and R' are variable groups. TI, stands for tetrahedral 




presence in the former acylase of two cysteines 
that form a disulfide bond (Verhaert et al., 1997). 
Penicillin V acylases - Penicillin V 
acylases (PVAs) catalyse the hydrolysis and 
synthesis of phenoxyacetyl substituted β-lactam 
antibiotics (Fig. 6). The molecular weights of 
these acylases vary from 83.2 kDa in Fusarium sp. 
SKF 235 to 140 kDa in Bacillus sphaericus, and 
their subunit composition from monomer to 
tetramer, respectively. The optimum pH values for 
the penicillin V acylases range between pH 5.6-
8.5, which is lower than found for the PA (pH 6.5-
8.5, (Margolin et al., 1980; Schumacher et al., 
1986)) and can be an advantage in an industrial 
process since the chemical degradation of 6-APA 
is less at lower pH-values (Shewale and 
Sudhakaran, 1997). The PVAs are mainly 
produced intracellularly and can be found in many 
different organisms. Only the gene encoding the 
penicillin V acylase of Bacillus sphaericus (PV, 
(Olsson et al., 1985)) has been cloned and studied 
in detail. The amino acid sequence of this β-
lactam acylase does not show significant 
homology with the sequences of known penicillin 
G acylases. However, the crystal structure of PV 
reveals an N-terminally located cysteine and the 
same typical fold as found for PA (Suresh et al., 
1999). Therefore it can be concluded that despite 
its different subunit size and native composition, 
the penicillin V acylase of B. sphaericus belongs 
to the same structural family as penicillin G 
acylases. 
Ampicillin acylases - Ampicillin acylases 
are defined as β-lactam acylases that prefer 
antibiotics with a phenylglycine-derived side 
chain, such as ampicillin and cephalexin (Fig. 6). 
In 1972, the first organism to produce an 
ampicillin acylase was reported (Okachi et al., 
1972). Though, based on its substrate range 
presented in the literature a few years later 
(Shimizu et al., 1975), it must be concluded that 
this enzyme from K. citrophila belongs to the 
penicillin G acylase class. In 1973, an ampicillin 
acylase isolated from Pseudomonas melanogenum 
was described. This enzyme has a completely 
different substrate range than penicillin G acylases 
as it catalyzes both the synthesis and hydrolysis of 
ampicillin but shows no activity with penicillin G 
or V (Okachi et al., 1973). This substrate range 
corresponds with that of ealier reported activity of 
the α-amino acid ester hydrolases (AEHs) by 
Takahashi et al. (1972). Both the ampicillin 
acylase and the AEHs need the α-amino group for 
activity and have subunits of 70-72 kDa. In this 
thesis these enzymes will be referred to as AEHs 
and as they are the main subject of this thesis their 




The cephalosporin acylases (CAs) prefer 
β-lactam antibiotics with a cephalosporanic acid 
derived nucleus, such as cephalosporin C and/or 
glutaryl 7-aminocephalosporanic acid as their 
substrates. Under physiological conditions, the 
side chains of glutaryl 7-ACA and cephalosporin 
C have charged groups. Therefore, cephalosporin 
acylases (CAs), just as the α-amino acid ester 
hydrolases but unlike penicillin acylases, can 
accept β-lactam antibiotics with a charged side 
chain as their substrate (Fritz-Wolf et al., 2002). 
The preferred substrate of all cephalosporin 
acylases appears to be glutaryl 7-ACA. However, 
cephalosporin acylases that have noticeable 
activity with cephalosporin C are very interesting 
from an industrial point of view and are therefore 
often referred to as a cephalosporin C acylases 
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(CCA) (Kim et al., 2000). The best CCA is found 
in Pseudomonas sp. N176, with a relative activity 
of 4% on cephalosporin C compared to that on 
glutaryl 7-ACA. By site-directed mutagenesis its 
relative activity on cephalosporin C could be 
further improved to 6% (Ishii et al., 1995; Saito et 
al., 1996). 
An alternative classification for the CAs 
has been proposed on basis of gene structure, 
molecular mass, and enzymatic properties. The ten 
CAs of which the genes have been cloned were 
divided into five classes (Li et al., 1999). The CAs 
of class I to IV consist of an α- and β-subunit 
which vary in size from 16 to 40 and 54 to 22 
kDa, respectively. The only class-V CA is the 7 β-
(4-carboxybutanamido)-cephalosporanic acid 
acylase from Bacillus laterosporus, which is 
composed of a single peptide of 70 kDa (Aramori 
et al., 1991b). The amino acid sequences of the 
enzymes of classes I to III show 15-30% identity 
with each other and with the different known PAs. 
The identity with PAs is concentrated at the N-
terminal part of the β-subunit, with complete 
conservation of the N-terminal nucleophile. In 
addition, it has been found that most of these CAs 
are subjected to post-translational processing from 
a preprotein (Aramori et al., 1991a; Li et al., 
1999; Matsuda et al., 1987) as described for PA. 
The similarity between CAs and PAs was 
confirmed by the recently solved crystal structure 
of the intracellular heterodimeric CA of P. 
diminuta (class I CA, with α and β subunits of 24 
and 63 kDa, respectively) and that of CA from yet 
another Pseudomonas sp. (class was not assigned). 
Both structures resembled the Ntn-hydrolase fold 
of the E. coli PA structure (Fritz-Wolf et al., 2002; 
Kim et al., 2000). Additionally, the structure of 
CA from Pseudomonas sp. N176 (Class III CA) 
(Kinoshita et al., 2000) could be solved by 
molecular replacement using the E. coli PA 
structure, indicating that the CAs of class I to III 
belong to the Ntn-hydrolase superfamily. 
The cephalosporin acylases of class IV and 
V show no significant sequence identity with any 
other β-lactam acylase (Aramori et al., 1991b). 
However, the subunits of class IV CAs are derived 
from a common precursor protein and their amino 
acid sequences show significant homology 
(>30%) with the Ntn-hydrolase γ-
glutamyltranspeptidase from E. coli, including the 
conservation of the N-terminally located 
nucleophilic threonine of the peptidase (Ishiye and 
Niwa, 1992; Suzuki and Kumagai, 2002), 
indicating that also the class IV CAs are Ntn-
hydrolases. 
Thus, in addition to the PAs and PVs, the 
CAs from class I to IV also belong to the Ntn-
hydrolase superfamily, even though in most cases 
there is little or no sequence identity. Up to now it 
remains unclear to which structural family the 




All the β-lactam acylases structurally 
and/or genetically characterised thus far have been 
identified as a member of the Ntn-hydrolase 
superfamily. The enzymes in this family are 
activated through autoproteolytic processing 
catalysed by a residue, which after processing is 
located at the N-terminus of the β-chain. This 
residue has two catalytic functions, it is both the 
nucleophile and the base in catalysis and is either 
a serine, a threonine or a cysteine. Structurally, the 
Ntn-hydrolase superfamily was defined as 
enzymes that show a typical αββα-fold. Up to 
now, this superfamily consists of markedly 
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different enzymes with respect to their in vivo 
function, size, subunit composition and substrate 
range, but they all catalyse amide bond hydrolysis. 
Enzymes that have been grouped into this 
superfamily so far include the penicillin G, 
penicillin V and cephalosporin acylases, 
proteasomes, a glucosamine 6-phosphate synthase, 
an aspartylglucosaminidase, L-aminopeptidase-D-
Ala-esterase/amidase, class II glutamine 
amidotransferases, γ-glutamyltranspeptidase and 
recently, based on sequence similarity with 
penicillin V acylases, the peptidase family U34 
(which includes enzyme such as choloylglycine 
hydrolases and isopenicillin N acyltransfereses) 
was added (Kim et al., 2000; Oinonen and 
Rouvinen, 2000; Pei and Grishin, 2003; Suzuki 
and Kumagai, 2002). 
 
Classification of β-lactam acylases 
Although old-fashioned, the nomenclature 
according to the preferred β-lactam antibiotic 
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Figure 8. Dendrogram of representative Ntn-hydrolase β-lactam acylases. The acylases are indicated by their 
natural host species. The bold circles indicate the classical classification based on substrate specificity: 

, 
penicillin G acylases; ---, cephalosporin acylases; and, 
  , penicillin V acylase. Boxed species refer to 
acylases of which the structure was solved. As no sequence or structural similarity with other β-lactam acylases 
has been found for the glutaryl acylase from B. laterosporus (class-V CA) this enzyme was not included in the 
dendrogram. All the β-lactam acylases indicated in the dendrogram are structurally related as they all belong to 




groups found in the classification based on the 
similarity of the amino acid sequences of the 
different β-lactam acylases (Fig. 8). In the latter 
classification, the penicillin G, penicillin V and 
cephalosporin acylases form separate groups as 
well. The CAs, however, are not confined to one 
specific group but are divided in three separate 
clusters, which closely resembles the alternative 
classification proposed for the CA described 
above. The fact that according to their three-
dimensional structure or sequence analysis, both 
members of penicillin and cephalosporin acylase 
classes belong to the Ntn-hydrolase superfamily 
indicates that there is an extended evolutionary 
relationship among the different β-lactam 
acylases. The question is whether the class-V CA 
from B. laterosporus and the ampicillin acylases 
or better the α-amino acid ester hydrolases (of 
which no amino acid sequence is available) also 
belong to this structural family. The results 
presented further in this thesis will show that this 
is not the case but that they instead belong to 
another superfamily of hydrolytic proteins. 
 
α-AMINO ADIC ESTER HYDROLASES 
 
In search for organisms able to synthesise 
β-lactam antibiotics that have a free amino group 
in their side chain, Takahashi et al. reported the 
ability of some bacteria to synthesise unnatural 
cephalosporins by the acylation of 7-
aminocephem compounds with α-amino acid 
esters in 1972 (Takahashi et al., 1972). The 
enzymes responsible for this activity were named 
α-amino acid ester hydrolases (AEHs) as i) their 
substrate range was limited to acyl donors with an 
α-amino group, ii) they preferred esters over 
amides and iii) because enzymes that can catalyse 
both transfer and hydrolysis reactions are referred 
to as hydrolases according to the rules for enzyme 
nomenclature (Takahashi et al., 1974). In the 
period from their discovery up to 1990, the α-
amino acid ester hydrolases of five organisms had 
been purified and their substrate specificity was 
determined: Xanthomonas citri (α4, subunit size 
72 kDa) (Kato et al., 1980a), X. rubrilineans (α4, 
subunit size 72 kDa) (Krest'ianova et al., 1990), X. 
sp. (α4, subunit size 70 kDa) (Blinkovsky and 
Markaryan, 1993), Acetobacter turbidans (α2/β2, 
subunit size 70/72 kDa, respectively) (Ryu and 
Ryu, 1987) and P. melanogenum (α2, subunit size 
72 kDa) (Kim and Byun, 1990b). All these AEHs 
show an absolute need for the α-amino group, 
which makes them very suitable for the synthesis 
of β-lactam antibiotics with a phenylglycine side 
chain, such as ampicillin or cephalexin, and 
derivatives thereof, such as amoxicillin and 
cephadroxil (Fig. 4). Unfortunately, they do not 
exhibit absolute stereospecificity as they 
hydrolyse esters of both D- and L- amino acids. 
However, the preference for a specific 
configuration of a particular amino acid has been 
observed (Fernandez-Lafuente et al., 2001). The 
pH optimum of the AEHs varies between pH 6.0 – 
6.5 and the optimal temperatures vary within the 
range of 35-45 °C. The preferred β-lactam 
antibiotic substrate is cephalexin (Kato et al., 
1980b; Kim and Byun, 1990b; Takahashi et al., 
1974). Therefore, according to the classical β-
lactam acylase nomenclature, the AEHs should be 
classified as cephalexin acylases (Kato et al., 
1980b; Nam et al., 2001; Ryu and Ryu, 1988). 
Alternatively, they belong to class III of the α-






The AEHs catalyse two reactions, the N-
acylation of β-lactam nuclei with α-amino acid 
groups to give the corresponding semi-synthetic 
β-lactam antibiotic, and the hydrolysis of α-amino 
acid esters or β-lactam antibiotics (Fig. 9). Based 
on the observations that i) the hydrolytic and 
transfer reactions showed identical 
substrate.specificities and displayed the same pH-
optimum; ii) the addition of nucleus diminished 
the hydrolysis rate of the activated ester, but with 
the corresponding amount of β-lactam antibiotic 
formed, the overall ester consumption remained 
unchanged and iii) the ratio of hydrolysis versus 
transfer rate did not depend on the ester moiety of 
the acyl donor, it has been concluded that the 
AEHs catalyse their reactions through a common 
acyl-enzyme intermediate (Blinkovsky and 
Markaryan, 1993; Kato, 1980; Takahashi et al., 
1974). The acyl-enzyme mechanism corresponds 
to the mechanism described penicillin acylases 
and for peptide hydrolysis by serine hydrolases. In 
such a mechanism, the substrate first associates 
with the enzyme to form a noncovalent enzyme-
substrate complex (Michaelis-Menten complex) 
followed by the acylation of the active site serine 
to give the acyl-enzyme intermediate (Fig. 10). 
This acyl-enzyme is attacked by a nucleophile 
(AcA, acyl acceptor) to give the enzyme-product 
complex from which the product is released. In 
case of the AEHs and PAs the acyl side chain can 
be transferred to water or to amine nucleophiles 
(like β-lactam nuclei) resulting in hydrolysis or 
formation of a semi-synthetic β-lactam antibiotic, 
respectively (Kato, 1980; Takahashi et al., 1974).  
 
Catalytic triad 
Despite the similarity of the proposed 
mechanism of the AEHs with that described for 






































Figure 9. Cephalexin synthesis and hydrolysis reactions performed by AEHs. PGM, 
phenylglycine methyl ester; 7-ADCA, 7-aminodesacetoxycephalosporanic acid and PGA, 
phenylglycine acetic acid. 
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AEH activity by serine hydrolase inhibitors like 
phenylmethylsulfonyl fluoride (PMSF) or 
diisopropylphosphorylfluoride (DIPF) was found 
(Blinkovsky and Markaryan, 1993; Ryu and Ryu, 
1988). Chemical modification studies on the AEH 
from A. turbidans indicated the importance of a 
histidine residue (Ryu and Ryu, 1988), which was 
confirmed by similar studies on the enzyme of P. 
melanogenum (Kim and Byun, 1990a). 
Additionally, for the enzyme of X. citri it was 
found that both an amino group and a carboxylic 
acid group were essential for catalysis (Nam et al., 
1985). Therefore, it is likely that in the AEHs 
multiple amino acids are essential in catalysis 
which might indicate a different mechanism than 
found for other β-lactam acylases. 
In the proteolytic enzyme chymotrypsin, 
the first existence of three active site residues, a 
nucleophile, a base and an acid, present in a 
configuration now known as the catalytic triad 
was described. In chymotrypsin these residues are 
a serine, a histidine, and an aspartate, respectively. 
Nowadays, many variants of this classical 
catalytic triad are found in proteolytic and non-
proteolytic enzymes (Dodson and Wlodawer, 
1998). For example, in a protease from the 
hepatitis A picornavirus the nucleophilic serine is 
replaced by a cysteine residue (Dodson and 
Wlodawer, 1998) and in the haloalkane 
dehalogenase from Xanthobacter autotrophicus by 
an aspartate (Verschueren et al., 1993). In 
acetylcholine esterase from Torpedo californica, 
the acid is replaced by the similar glutamate and in 
an esterase from Streptomyces scabies it is 
replaced by two main chain carbonyl oxygens 
(Wei et al., 1995). In β-lactamases, the generally 
conserved histidine (base) is replaced by a lysine 
(Dubus et al., 1994). Sometimes an amino acid 
has a double role. For example, in the Ntn-
hydrolase family the OH and α-NH2 functions of 
the N-terminal serine serve as a nucleophile and a 
base, respectively (Duggleby et al., 1995). 
Alternatively, in some proteases a catalytic tetrad 
rather than a triad is conserved, in which the 
fourth residue is either a serine or a cysteine that 
stabilizes the other catalytic residues (Krem and 
Di Cera, 2001). 
The catalytic triad and variants thereof are 
present in many different structural folds. 
Examples of protein folds that provide a scaffold 
for a classical catalytic triad are the trypsin- and 
subtilisin-like serine protease-, cysteine 
proteinase-, flavodoxin-like- and the α/β- 
hydrolase-fold enzymes. Further inhibition studies 
and the three-dimensional structure are needed to 









Figure 10. The proposed reaction scheme for AEH involving an acyl-enzyme 
intermediate. In the scheme E is short for enzyme and represents the AEHs; AcD, acyl 
donor, either an α-amino ester or an α-amino amide; P, the first product, either an alcohol or 
an amide; E-Ac, acyl-enzyme intermediate; AcA, acyl acceptor, amide or water; Q, transfer 




Cloning of the AEH encoding genes 
For an extended detailed analysis of the 
AEHs, large quantities of enzyme are needed 
which can easily be obtained when the encoding 
genes are available for overexpression. One 
attempt to clone an AEH-encoding gene was 
under taken by Nam et al. using an 
immunochemical detection method. Therefore, 
two λ gt11 genomic libraries of A. turbidans 
ATCC 9325 were made and screened with a 
polyclonal mouse antibody against purified A. 
turbidans AEH (Nam and Ryu, 1988). Two 
positive clones were obtained, one producing a 
protein of 108 kDa and the other one of 180 kDa. 
From restriction analysis, Nam et al. concluded 
that some parts of the construct and insert DNA 
were deleted during the replication in the host 
cells, which hampered the cloning of the full gene. 
In their conclusion they stated that they would use 
the insert DNA of the positive clones as probes to 
clone the full gene. However, up to now, no report 
has been made of the successful cloning of the A. 
turbidans AEH gene by Nam et al. Another 
attempt to clone an AEH was undertaken by 
Alonso and García et al. (Alonso and García, 
1996). They constructed a genomic library of the 
total DNA of X. campestris pv. citri IFO 3835 in 
pBR322 and transformed it to the leucine deficient 
host E. coli HB101. The selection procedure was 
based on the auxotrophic complementation of the 
host, growing it on a minimal medium containing 
D-alanine-L-leucine. It was expected that when a 
clone harboured and expressed the gene encoding 
the AEH, it could hydrolyse this dipeptide, 
releasing L-leucine required for growth. In this 
way, one positive clone was obtained of which the 
extract, unfortunately, was not able to hydrolyse 
ampicillin. Sequence analysis and homology 
searches showed that the cloned gene encoded a 
proline iminopeptidase. Thus, the two cloning 
attempts described in literature thus far, which 
were both based on screening for expressed 
enzyme, were unsuccessful. This propably 
hampered the introduction into an industrial semi-
synthetic β-lactam synthesis process for which 
they have promising properties 
 
BIOCATALYTIC PRODUCTION OF SEMI-
SYNTHETIC β-LACTAM ANTIBIOTICS 
 
Nowadays, the β-lactam antibiotics 
penicillin G and V are fermentatively produced at 
an estimated annual market volume of 33,000 tons 
world-wide using Penicillium strains. About 
10,000 tons of this is used as a starting material 
for semi-synthetic β-lactam antibiotics (Elander, 
2003). The production of the latter comprizes two 
processes, the hydrolysis of the fermentative β-
lactam antibiotic and the condensation reaction of 
the obtained free β-lactam nucleus (expanded to 7-
ADCA or not) with a new side chain. The 
enzymes described above, especially PA from E. 
coli, and the AEHs are interesting from an 
industrial point of view as they can be used in the 
development of green alternatives for the chemical 
routes in the production of semi-synthetic 
β-lactam antibiotics. 
 
Hydrolysis of fermentative β-lactam antibiotics 
Chemical hydrolysis - Although the 
enzymatic removal of the side chain of 
fermentative penicillins was already demonstrated 
in 1960, it was not implemented in industry 
because at that time enzymes were considered 
difficult to work with. Additionally, they were 
hard to obtain in large quantities and difficult to 
recover, making the use of enzymes expensive. 
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Therefore, alternative chemical routes were 
developed for the isolation of β-lactam nuclei 
from fermentatively produced β-lactam antibiotics 
(Verweij and Vroom, 1993). The chemical 
hydrolysis is complicated due to the high 
reactivity of the β-lactam bond. However, after 
protecting the carboxyl group of the β-lactam 
nucleus with silyl chemistry, the side chain amide 
bond can be selectively cleaved in the presence of 
phosphorus pentachloride and alcohol at low 
temperatures. The development of this so-called 
‘Delft cleavage’ led to a very efficient and 
inexpensive one-pot synthesis of 6-APA. This 
procedure could be applied efficiently for the 
chemical cleavage of cephalosporin C as well, 
resulting in the availability of the 7-ACA nucleus 
for the production of semi-synthetic 
cephalosporins (Bruggink, 2001; Verweij and 
Vroom, 1993).  
Enzymatic hydrolysis -The development of 
robust and immobilised biocatalyst systems 
(enabling recycling) allowed the introduction of 
an economically feasible biocatalytic process for 
the hydrolysis of fermentative penicillins using the 
penicillin G or V acylases in the mid 1980s (Fig. 
11) (Shewale and Sudhakaran, 1997; Van de 
Sandt and De Vroom, 2000). The cloning of the 
genes encoding PVAs and PGAs (see above) 
enabled efficient production of large quantities of 
enzyme in overexpression systems contributing to 
the success of the introduction of these 
biocatalysts. The use of enzymes allowed the 
hydrolytic process to be performed in water, at 
ambient temperature, and with only a titrant as 
auxiliary chemical, which led to a 5-fold reduction 
of the produced waste volume compared to the 
chemical route (Van de Sandt and De Vroom, 
2000). 
Also in the production of cephalosporin 
related β-lactam nuclei biocatalysis was 
introduced. A two-step enzymatic process 
replaced the chemical hydrolysis of cephalosporin 
C to yield 7-ACA, since no enzyme was available 
to directly deacylate cephalosporin C. A D-amino 
acid oxidase is used in the conversion of the 
α-aminoadipyl to a glutaryl side chain, which is 
subsequently hydrolysed by a glutaryl 7-ACA 
acylase to yield 7-ACA (Fig. 11). The other 
important cephalosporin nucleus is 
7-aminodesacetoxycephalosporanic acid (7-
ADCA, Fig. 11, (5)). Chemically, this nucleus was 
produced from penicillin G by chemical ring 
expansion using peracetic acid, hydrogen bromide 
and pyridine, converting penicillin G into 
cephalosporin G, and subsequent chemical 
deacylation (Delft cleavage). In a green 
alternative, the deacylation of cephalosporin G by 
PA was introduced (Fig. 11, (3) to (5)).  
A completely green route to 7-ADCA can 
be obtained by introduction of a new fermentation 
process using a Penicillium chrysogenum strain 
expressing the expandase gene from Streptomyces 
clavuligerus. Experiments showed the successful 
production of adipoyl-7-ADCA (Robin et al., 
2001) of which the side chain can easily be 
removed by a glutaryl acylase related enzyme. 
The industry has started with the implementation 
of this fully biosynthetic manufacturing process 
(Bruggink, 2001). Alternatively, the expandase 
gene from Streptomyces clavuligerus can replace 
the gene encoding the bifunctional 
expandase/hydroxylase activity in the 
cephalosporin C production strain Acremonium 
chrysogenum, resulting in the production of 
desacetoxycephalosporin C. Subsequent 













































































acylase yields 7-ADCA (Velasco et al., 2000). 
 
Synthesis of semi-synthetic β-lactam antibiotics 
Chemical synthesis - To couple synthetic 
side chains to the free β-lactam nuclei two major 
chemical routes are used, the Schotten-Baumann 
condensation with acid chloride and the Dane salt 
method. In the robust acid chloride process, the 
phenylglycine side chain is activated by making 
its acid chloride hydrochloride that is 
subsequently coupled to a silyl-protected 6-APA 
to obtain ampicillin (Fig 12, A). In the Dane salt 
method the side chain is coupled via its amine 
group to a β-dicarbonyl compound. The resulting 
anhydride (the Dane salt is subsequently 
converted to a mixed activated side chain) that can 
directly be coupled to the free β-lactam nucleus in 
the presence of an organic base (Fig. 12, B) 
(Bruggink, 2001). Unfortunately, both methods 
need low temperatures and organic solvents 
resulting in a considerable burden for the 
environment. 
Enzymatic synthesis - To shift from 
chemical to an enzyme-catalysed synthesis of 
semi-synthetic β-lactam antibiotics, two types of 
enzymes have been explored for their
Figure 11. Production of semi-synthetic β-lactam antibiotics. (1), Penicillin G; (2), cephalosporin C; (3), 
cephalosporin G; (4), 6-APA; (5), 7-ADCA; (6), glutaryl-7-aminocephalosporanic acid; (7), 7-ACA and (8) 
Cephem nuclei with different substituents. Bold arrows indicate routes dominated by biocatalysis within industry. 










































































applicability, the penicillin acylase from E. coli 
and the α-amino acid ester hydrolases (AEHs) 
(Bruggink, 2001; Bruggink et al., 1998). These 
enzymes can couple a synthetic side chain to the 
free β-lactam nucleus producing a semi-synthetic 
β-lactam antibiotic in a thermodynamically or 
kinetically controlled process. 
Thermodynamic coupling - In a 
thermodynamic coupling, the semi-synthetic β-
lactam antibiotic is formed by an enzyme-
catalysed condensation between the free 
carboxylic acid and the β-lactam nucleus. The 
enzyme influences the rate at which the 
equilibrium is reached and the thermodynamic 
equilibrium between the products and reactants 
under the conditions used determines the 
maximum product accumulation. Since the 
product concentration at equilibrium is often low 
(Blinkovsky and Markaryan, 1993; Schroën et al., 
1999), this reaction is considered feasible only 
when the equilibrium can be shifted towards 
synthesis by product removal, for example by 
crystallisation or complexation (Schroën et al., 
1999). For the production of α-amino substituted 
β-lactam antibiotics, phenylglycine (PG) and 
derivatives thereof needs to be coupled to the 
nucleus. In de pH-range (4-9) where the enzymes 
are active, the amino group of PG is mainly 
present in its charged form (Blinkovsky and 
Markaryan, 1993; Schroën et al., 1999). Penicillin 
acylase from E. coli does not accept a charged 
amino group (Margolin et al., 1980), while the 
AEH of X. citri does (Blinkovsky and Markaryan, 
1993). Unfortunately, thermodynamic coupling of 
PG to 7-ADCA by AEH without product 
complexation or removal resulted in only small 
amounts of antibiotic due to unfavourable 
thermodynamic conditions (Blinkovsky and 
Markaryan, 1993; Schroën et al., 1999). 
Kinetic coupling - In the kinetically 
controlled process an activated substrate is used 
(amide or ester) to acylate the enzyme. 
Subsequent transfer of the acyl group to an 
accepting nucleophile leads to an acylated 
Figure 12. Chemical routes to semi-synthetic β-lactam antibiotics. (A) Schotten-Baumann condensation with 




product. The kinetic properties of the enzyme and 
the conversion process allow the transient 
accumulation of high levels of synthesis products 
(Qmax) before equilibrium is reached. However, 
unwanted enzyme-catalysed reactions take place 
as well, like the hydrolysis of the activated acyl 
donor and the hydrolysis of the condensation 
product. The level of Qmax is determined by the 
kinetic parameters of the enzyme, and is 
independent of the enzyme concentration. Another 
parameter used to evaluate the synthesis reaction 
is the ratio between the condensation and 
hydrolysis product, the so-called 
synthesis/hydrolysis (S/H) ratio. In this study, the 
S/H ratio is determined from the product 
concentrations at Qmax (S/Hmax) and from the 
formation rates in the beginning of a synthesis 
reaction (S/H). Both these ratios are determined 
by the enzyme and reaction conditions like 
temperature, ionic strength and pH (Kasche, 
1986). 
 
AEH in the synthesis of semi-synthetic β-
lactam antibiotics 
The catalytic properties and substrate 
range of AEHs have many properties that make 
them interesting candidates for application in the 
kinetically controlled synthesis of α-amino 
substituted semi-synthetic β-lactam antibiotics. 
For example, due to their low affinity for amides, 
low product (amide) hydrolysis is expected which 
might lead to a high level of product 
accumulation. Furthermore, the AEHs are not 
inhibited by phenylacetic acid (PAA) (Blinkovsky 
and Markaryan, 1993), which may be present in 
small amounts in 6-APA that is produced from 
penicillin G. If PA is used to couple 6-APA to 
synthetic side chains, the starting materials must 
be free of any traces of PAA, since the E. coli PA 
is strongly inhibited by it. The use of AEHs would 
eliminate the need for purification of the β-lactam 
nuclei and any losses accompanying it. To reduce 
the number of operations and decrease the losses 
of 6-APA accompanying them in a synthesis 
process, a one-pot synthesis in which the 
enzymatic hydrolysis of penicillin G and the 
coupling of the obtained nucleus to synthetic side 
chains take place in one reaction vessel is very 
attractive. Due to the high concentrations of PAA 
that accumulate, it is unfavourable to use E. coli 
PA in this process. However, the lack of inhibition 
by PAA of the AEHs, might make these enzymes 
an interesting alternative. The applicability of 
AEH from A. turbidans to synthesise amoxicillin 
in the presence of PAA has been demonstrated, 
although removal of PAA and remaining 
penicillin G up to a certain level is preferred to 
reduce the ionic strength and increase the yield 
(Diender, 2001). Another advantage of the AEHs 
is that they have a high preference for the D-
isomer of phenylglycine methyl ester (D-PGM, the 
activated side chain) in the acylation reaction. 
Therefore, synthesis reactions can be carried out 
starting from a racemic mixture of phenylglycine 
methyl ester (Fernandez-Lafuente et al., 2001), 
making a resolution process to produce 
enantiopure phenylglycine methyl ester 
unnecessary (Bruggink, 2001). Although, from an 
industrial point of view introducing racemic side 
chain donors in the condensation reaction is not 
interesting since it would lead to a very 
complicated downstream processing, eventually 
nullifying the benefits (Bruggink et al., 1998). 
Finally, the lower pH optimum of the AEHs as 
compared to PAs is advantageous since the 
precursors and products of β-lactam antibiotic 
synthesis are more stable at lower pH (Schroën et 
al., 1999; Shewale and Sudhakaran, 1997). 
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Additionally, the ability of the AEHs to synthesise 
ampicillin from D-PGM with high efficiency at 
low temperatures (5 °C) is very beneficial, as the 
low temperature contributes to the stability of the 
precursors and formed product, reducing 
(unproductive) losses. 
Although the AEHs seem to have many 
advantages over PA, penicillin acylases were first 
introduced in the kinetically controlled production 
of semi-synthetic β-lactam antibiotics 
(cephalexin) (Bruggink et al., 1998). This was 
mainly due to the improved gelatin-based 
immobilisation of PA, which had been optimised 
for the highest molar ratio of product to hydrolysis 
product at 10% conversion (S/H ratio). 
Additionally, the gene encoding PA was cloned 
and its expression had been optimised providing in 
the need for large quantities of enzyme. 
Furthermore, conditions for use in an industrial 
process had already been established with the 
hydrolysis of the fermentative β-lactam 
antibiotics. The introduction of biocatalysis in the 
coupling process (Fig. 11) reduced the amount of 
organic reagents and solvents needed with a factor 
5 and made the use of liquid nitrogen and 
halogenated solvents superfluous (Bruggink, 
2001). The conversion of a chemical to an 
enzymatic coupling processes for other semi-
synthetic β-lactam antibiotics, such as ampicillin, 
amoxicillin, cefaclor and cefadroxil, needs further 
development to allow integration in the industrial 
production. 
Thus, introduction of AEHs in biocatalysis 
has very likely been hampered by the limited 
availability of the enzymes, caused by the low 
expression level of the AEHs in the natural hosts 
and the absence of cloned genes and 
overexpression systems. Furthermore, a detailed 
kinetic and mechanistic insight, which can provide 
a rationale for process optimisation and enzyme 
engineering, has been lacking so far. 
 
SCOPE AND OUTLINE OF THIS THESIS 
 
The work presented in this thesis was 
performed as part of the so-called Clusterproject 
Catalysis in Fine Chemistry. In the Clusterproject 
universities supported by industry studied the 
possible introduction or improvement of 
biocatalytic and non-biocatalytic routes in the 
production of β-lactam antibiotics from many 
different angles. The disciplines that were 
represented varied from process technology and 
organic synthesis to enzymology and structural 
biology. The research of which the results are 
described in this thesis involved the search for and 
characterisation of enzymes that can be used for 
the preparation of α-amino substituted semi-
synthetic β-lactam antibiotics. To find the best 
enzyme for this process we first compared various 
strains expressing different classes of β-lactam 
acylases for their capacity to synthesis ampicillin 
from phenylglycine ester or amide and the 6-APA 
nucleus (Chapter 2). The strains that expressed α-
amino acid ester hydrolases showed the best 
biocatalytic properties and were selected for 
further studies. As mentioned before, AEHs were 
not easily available due to low expression levels in 
the wild-type organisms and complicated 
purification procedures. To facilitate further 
studies such as the determination of the catalytic 
mechanism and X-ray structure, it was decided to 
clone the genes encoding the AEHs. To that 
purpose, genome libraries of the total DNA from 
each organism were made (Chapter 2, 3 and 5). 
We attempted to locate the genes encoding the 
AEHs in the separate libraries by several activity 
assays (Chapter 2), but unfortunately this was not 
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successful. Probably, the enzymes were not 
correctly expressed in the library host and it was 
decided to purify the AEHs from the wild-type 
organisms. From the pure enzymes, parts of the 
amino acid sequences were determined, which in 
turn were used to design a specific DNA probe 
enabling the location of the genes in the library via 
DNA hybridisation. In this way the genes from A. 
turbidans ATCC 9325 and X. citri IFO 3835 were 
cloned and characterised (Chapter 3 and 5, 
respectively). 
In Chapter 4 we provide more insight in 
the catalytic mechanisms of the AEHs through 
labelling with p-nitrophenyl p'-guanidino benzoate 
(p-NPGB) and the subsequent identification of the 
catalytic nucleophile of the AEH from A. 
turbidans by mass spectrometry. Additional 
sequence analysis, homology searches and site-
directed mutagenesis lead to the identification of a 
catalytic triad in the AEHs. Database searches 
with the cloned AEHs identified a new class of β-
lactam acylases of more than 7 putative AEHs that 
showed at least 60% identity. The catalytic 
mechanism of the AEHs was further elucidated by 
the crystallographic studies on the AEH of X. citri 
(Chapter 5). The structure revealed a rather 
complex but elegant system of three separate 
domains comprising one subunit. By combining 
some experimentally determined features with the 
structure, insight was obtained in the catalytic 
mechanism of the AEHs. 
In Chapter 6 we describe the first site-
directed mutagenesis experiments of the AEH 
from A. turbidans to improve its biocatalytic 
performance. These studies resulted in two 
mutants with improved properties. Chapter 7 
presents the main conclusions of this thesis and 
will elaborate on future research needed to gain 
more insight in the structure-function relationship 
of this new class of β-lactam acylases.
